5th Jun 2007 10:27
GW Pharmaceuticals PLC05 June 2007 GW Pharmaceuticals plc Notification of Results Porton Down, UK, 5 June 2007: GW Pharmaceuticals plc (AIM: GWP) will beannouncing its interim financial results for the six months ended 31 March 2007on Tuesday 19 June. Enquiries: Financial Dynamics 020 7831 3113Gemma Cross Brown Notes to Editors About GW Pharmaceuticals GW was founded in 1998 and listed on the AiM, a market of the London StockExchange in June 2001. Operating under license from the UK Home Office, thecompany is developing cannabis-derived pharmaceutical products for patients withmultiple sclerosis, neuropathic pain, cancer pain, spinal cord injury,rheumatoid arthritis, and other severe medical conditions. GW has assembled a team of over 100 scientists with extensive experience indeveloping both plant-based prescription pharmaceutical products and medicinescontaining controlled substances. GW is dedicated to developing treatmentoptions that alleviate pain symptoms in patients who suffer from seriousailments. For further information, please visit the Company's website: www.gwpharm.com This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
GWP.L